• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病中威尔姆斯瘤基因WT1的突变。

Mutations in the Wilms' tumor gene WT1 in leukemias.

作者信息

King-Underwood L, Renshaw J, Pritchard-Jones K

机构信息

Institute of Cancer Research, Sutton, Surrey, UK.

出版信息

Blood. 1996 Mar 15;87(6):2171-9.

PMID:8630376
Abstract

The tissue-specific Wilms' tumor gene WT1 is expressed in a range of acute leukemias and hematopoietic cell lines. Using single-strand conformational polymorphism analysis, we have found mutations in the WT1 gene in 4 of 36 acute leukemias. WT1 mutations are found in 15% of cases of acute myeloid leukemia, in which they are associated with a poor response to chemotherapy. The mutations comprise small insertions in exons 1 and 7 and a nonsense mutation in exon 9. All are predicted to produce a truncated WT1 protein with absence or disruption of the zinc finger region. These are the first mutations in the WT1 gene to be described in sporadic leukemia.

摘要

组织特异性的威尔姆斯瘤基因WT1在多种急性白血病和造血细胞系中表达。通过单链构象多态性分析,我们在36例急性白血病中的4例发现了WT1基因的突变。WT1突变见于15%的急性髓系白血病病例,这些病例对化疗反应不佳。这些突变包括外显子1和7的小插入以及外显子9的无义突变。预计所有这些突变都会产生截断的WT1蛋白,其锌指区域缺失或破坏。这些是散发性白血病中首次描述的WT1基因突变。

相似文献

1
Mutations in the Wilms' tumor gene WT1 in leukemias.白血病中威尔姆斯瘤基因WT1的突变。
Blood. 1996 Mar 15;87(6):2171-9.
2
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.多数人类急性白血病中存在威尔姆斯瘤基因(wt1)转录本和WT1核蛋白。
Leukemia. 1995 Jun;9(6):1060-7.
3
Mutation analysis of the WT1 gene in myelodysplastic syndromes.骨髓增生异常综合征中WT1基因的突变分析
Jpn J Cancer Res. 1998 Aug;89(8):821-4. doi: 10.1111/j.1349-7006.1998.tb00634.x.
4
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.迪尼-德拉斯综合征点突变对肾母细胞瘤抑制蛋白WT1的DNA结合活性的影响。
Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o.
5
Genotype/phenotype correlations in Wilms' tumor.肾母细胞瘤的基因型/表型相关性
Med Pediatr Oncol. 1996 Nov;27(5):408-14. doi: 10.1002/(SICI)1096-911X(199611)27:5<408::AID-MPO4>3.0.CO;2-Q.
6
Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.肾母细胞瘤患者WT1基因的胚系突变和体细胞突变
Int J Cancer. 1995 Nov 15;63(4):516-22. doi: 10.1002/ijc.2910630410.
7
Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.儿童非淋巴细胞性血液系统恶性肿瘤中WT1基因的突变
Genes Chromosomes Cancer. 1999 Jun;25(2):176-83.
8
The role of Wilms' tumor genes.肾母细胞瘤基因的作用。
J Med Invest. 1999 Aug;46(3-4):130-40.
9
Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance.威尔姆斯瘤(WT1)基因突变主要发生在急性髓系白血病中,可能导致耐药性。
Blood. 1998 Apr 15;91(8):2961-8.
10
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.威尔姆斯肿瘤抑制基因的种系突变与迪尼-德拉斯综合征患者泌尿生殖系统发育异常有关。
Cell. 1991 Oct 18;67(2):437-47. doi: 10.1016/0092-8674(91)90194-4.

引用本文的文献

1
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors.EWS-WT1 融合异构体在促结缔组织增生性小圆细胞肿瘤中建立致癌程序和治疗弱点。
Nat Commun. 2024 Aug 28;15(1):7460. doi: 10.1038/s41467-024-51851-3.
2
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia.维奈托克治疗急性髓系白血病及耐药机制的研究进展。
Cell Death Dis. 2024 Jun 12;15(6):413. doi: 10.1038/s41419-024-06810-7.
3
Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation.
急性髓系白血病患者中MiR-19b、MiR-25、MiR-17、WT1和CEBPA的表达失调及其与造血干细胞移植后移植物抗宿主病的关联
South Asian J Cancer. 2022 Apr 25;11(4):346-352. doi: 10.1055/s-0042-1742593. eCollection 2022 Oct.
4
The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia.肾母细胞瘤基因(WT1)表达作为急性髓系白血病微小残留病标志物的作用
J Clin Med. 2022 Jun 9;11(12):3306. doi: 10.3390/jcm11123306.
5
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.针对新鉴定的肽的 WT1 特异性 TCR 可针对急性髓系白血病和卵巢癌产生抗肿瘤反应。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-004409.
6
Gene Mutations, rs16754 Variant, and Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients.基因变异、rs16754 变体及过表达作为急性髓系白血病患者的预后因素
J Clin Med. 2022 Mar 28;11(7):1873. doi: 10.3390/jcm11071873.
7
Role of Biomarkers in FLT3 AML.生物标志物在FLT3急性髓系白血病中的作用。
Cancers (Basel). 2022 Feb 24;14(5):1164. doi: 10.3390/cancers14051164.
8
Super-Enhancers Dysregulations in Hematological Malignancies.血液系统恶性肿瘤中的超级增强子失调。
Cells. 2022 Jan 7;11(2):196. doi: 10.3390/cells11020196.
9
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia.急性髓系白血病中常见突变基因的小鼠模型
Cancers (Basel). 2021 Dec 8;13(24):6192. doi: 10.3390/cancers13246192.
10
Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia.突变是儿童急性髓系白血病中独立的不良预后因素。
Front Oncol. 2021 Apr 21;11:632094. doi: 10.3389/fonc.2021.632094. eCollection 2021.